Thrombosis
News
FDA explains dabigatran dose approval
The medical community was surprised when the Food and Drug Administration (FDA) approved the higher dose of dabigatran and not the lower dose last...
News
Dabigatran also recommended to treat AF
The new guidelines also included patients with atrial fibrillation with risk factors for stroke or blood clotting who do not have a prosthetic...
News
Dabigatran: lower hemorrhage risk than warfarin
A recent analysis of previous data found that while warfarin and dabigatran are comparable at preventing stroke in patients with atrial...
News
FDA approves dabigatran for AF patients
The US Food and Drug Administration (FDA) has approved dabigatran etexilate (Pradaxa) to prevent strokes and thrombosis in patients with atrial...
News
FDA panel recommends dabigatran: 9-0
The decision was based on the randomized, noninferiority RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) trial of 18,000...
News
Dabigatran comparable to warfarin for acute VTE
NEW ORLEANS—The direct thrombin inhibitor dabigatran etexilate is a safe, effective anticoagulant that, unlike warfarin, does not require routine...
News
Ticagrelor tops clopidogrel in recent study
Ticagrelor significantly reduced the rate of death from vascular causes, myocardial infarction, or stroke without an increase in major bleeding....
News
Dabigatran surpasses warfarin in stroke prevention
News
Docs recommend transdermal patch for HRT
News
Dabigatran safe, effective in elderly surgery patients
News
Study shows drug is safe and effective in cardiac patients
Bivalirudin was associated with a lower rate of major bleeding and death from cardiac and other causes at 30 days from treatment initiation.